MNPR

Monopar Therapeutics Inc. is a clinical-stage biopharmaceutical company based in Wilmette, Illinois, dedicated to developing proprietary therapies that enhance clinical outcomes for cancer patients. The company boasts a diverse pipeline of innovative drug candidates aimed at addressing critical unmet needs in oncology. By employing advanced drug formulation technologies to improve treatment efficacy and safety, Monopar is strategically positioned to make significant contributions to cancer care and establish itself as a prominent entity in the biopharmaceutical landscape.